Annual report pursuant to Section 13 and 15(d)

Composition of Certain Financial Statement Items

v3.19.3
Composition of Certain Financial Statement Items
 12 Months Ended
Sep. 29, 2019
Balance Sheet Related Disclosures [Abstract]  
Composition of Certain Financial Statement Items Composition of Certain Financial Statement Items
Accounts Receivable (in millions)
 
 
 
 
September 29, 2019
 
September 30, 2018
Trade, net of allowances for doubtful accounts of $47 and $56, respectively
$
1,046

 
$
2,667

Unbilled receivables
1,411

 
201

Other
14

 
36

 
$
2,471

 
$
2,904


The increase in unbilled receivables was primarily due to the adoption of new revenue recognition guidance in fiscal 2019 (Note 1). Accounts receivable, trade at September 30, 2018 included approximately $960 million related to the short payment in the second quarter of fiscal 2017 of royalties reported by and deemed collectible from Apple’s contract manufacturers. This same amount was recorded in customer-related liabilities (in other current liabilities) for Apple, since we did not have the contractual right to offset these amounts. In the third quarter of fiscal 2019, we entered into settlement agreements with Apple and its contract manufacturers to dismiss all outstanding litigation between the parties, and as a result, these amounts, as well as others, were settled.
Inventories (in millions)
 
 
 
 
September 29, 2019
 
September 30, 2018
Raw materials
$
77

 
$
72

Work-in-process
667

 
715

Finished goods
656

 
906

 
$
1,400

 
$
1,693


Property, Plant and Equipment (in millions)
September 29, 2019
 
September 30, 2018
Land
$
170

 
$
186

Buildings and improvements
1,546

 
1,575

Computer equipment and software
1,356

 
1,419

Machinery and equipment
4,007

 
3,792

Furniture and office equipment
86

 
85

Leasehold improvements
301

 
325

Construction in progress
182

 
79

 
7,648

 
7,461

Less accumulated depreciation and amortization
(4,567
)
 
(4,486
)
 
$
3,081

 
$
2,975


Depreciation and amortization expense related to property, plant and equipment for fiscal 2019, 2018 and 2017 was $674 million, $776 million and $684 million, respectively.
Goodwill and Other Intangible Assets. We allocate goodwill to our reporting units for annual impairment testing purposes. The following table presents the goodwill allocated to our reportable and nonreportable segments, as described in Note 8, as well as the changes in the carrying amounts of goodwill during fiscal 2019 and 2018 (in millions):
 
QCT
 
QTL
 
Nonreportable Segments
 
Total
Balance at September 24, 2017
$
5,581

 
$
741

 
$
301

 
$
6,623

Impairments (Note 10)
—

 
(22
)
 
(107
)
 
(129
)
Other (1)
6

 
(1
)
 
(1
)
 
4

Balance at September 30, 2018 (2)
5,587

 
718

 
193

 
6,498

Acquisitions
18

 
—

 
—

 
18

Impairments (Note 10)
—

 
—

 
(146
)
 
(146
)
Other (1)
(40
)
 
(1
)
 
(47
)
 
(88
)
Balance at September 29, 2019 (2)
$
5,565

 
$
717

 
$
—

 
$
6,282


(1)
Includes changes in goodwill amounts resulting from the sale of our mobile health nonreportable segment in fiscal 2019, foreign currency translation and purchase accounting adjustments.
(2)
Cumulative goodwill impairments were $812 million and $666 million at September 29, 2019 and September 30, 2018, respectively.
The components of other intangible assets, net were as follows (in millions):
 
September 29, 2019
 
September 30, 2018
 
Gross Carrying
Amount
 
Accumulated
Amortization
 
Weighted-average amortization period
(years)
 
Gross Carrying
Amount
 
Accumulated
Amortization
 
Weighted-average amortization period
(years)
Technology-based
$
5,958

 
$
(3,851
)
 
10
 
$
6,334

 
$
(3,461
)
 
10
Other
134

 
(69
)
 
9
 
149

 
(67
)
 
8
 
$
6,092

 
$
(3,920
)
 
10
 
$
6,483

 
$
(3,528
)
 
10

All of these intangible assets are subject to amortization and the amortization expense related to these intangible assets was $727 million, $785 million and $777 million for fiscal 2019, 2018 and 2017, respectively. Amortization expense related to these intangible assets is expected to be $610 million, $496 million, $399 million, $275 million and $121 million for each of the five years from fiscal 2020 through 2024, respectively, and $271 million thereafter. At September 29, 2019 and September 30, 2018, all acquired in-process research and development projects were completed and are being amortized over
their useful lives.
Equity Method and Non-marketable Equity Investments. The carrying values of our equity method and non-marketable equity investments are recorded in other noncurrent assets and were as follows (in millions):
 
September 29,
2019
 
September 30,
2018
Equity method investments
$
343

 
$
402

Non-marketable equity investments
787

 
650

 
$
1,130

 
$
1,052

Transactions with equity method investees are considered related party transactions. Revenues from certain services contracts were $152 million and $100 million with one of our equity method investees in fiscal 2019 and 2018, respectively, and revenues from certain license and services contracts were $165 million with two of our equity method investees in fiscal 2017. We eliminate unrealized profit or loss related to such transactions in relation to our ownership interest in the investee, which is recorded as a component of equity in net losses in investees in investment and other income, net. At September 29, 2019 and September 30, 2018, we had no accounts receivable from these equity method investees.
During fiscal 2019, non-marketable debt and equity securities (non-cash consideration) with an aggregate estimated fair value of $98 million were received related to a development contract with one of our equity method investees, which was recognized as revenues in fiscal 2019. In addition, during fiscal 2019, non-marketable equity securities (non-cash consideration) with an estimated fair value of $53 million were received in connection with the sale of certain assets as part of the Cost Plan (Note 10).
Other Current Liabilities (in millions)
 
 
 
 
September 29,
2019
 
September 30,
2018
Customer incentives and other customer-related liabilities
$
1,129

 
$
3,500

Accrual for EC fines (Note 7)
1,379

 
1,167

Income taxes payable
480

 
453

RF360 Holdings Put and Call Option (Note 9)
—

 
1,137

Other
470

 
721

 
$
3,458

 
$
6,978


Accumulated Other Comprehensive Income. Changes in the components of accumulated other comprehensive income, net of income taxes, in stockholders’ equity during fiscal 2019 were as follows (in millions):
 
Foreign Currency Translation Adjustment
 
Noncredit Other-than-Temporary Impairment Losses and Subsequent Changes in Fair Value for Certain Available-for-Sale Debt Securities
 
Net Unrealized Gains (Losses) on Other Available-for-Sale Securities
 
Net Unrealized Gain (Loss) on Derivative Instruments
 
Other Gains (Losses)
 
Total Accumulated Other Comprehensive Income
Balance at September 30, 2018
$
11

 
$
23

 
$
243

 
$
(13
)
 
$
1

 
$
265

Other comprehensive (loss) income before reclassifications
(110
)
 
—

 
(6
)
 
26

 
(19
)
 
(109
)
Reclassifications from accumulated other comprehensive income
—

 
—

 
(51
)
 
(5
)
 
—

 
(56
)
Other comprehensive (loss) income
(110
)
 
—

 
(57
)
 
21

 
(19
)
 
(165
)
Balance at September 29, 2019
$
(99
)
 
$
23

 
$
186

 
$
8

 
$
(18
)
 
$
100


Reclassifications from accumulated other comprehensive income included adjustments of $51 million to the opening retained earnings balance as a result of the adoption of new accounting guidance in the first quarter of fiscal 2019 related to financial instruments and hedge instruments (Note 1). Reclassifications from accumulated other comprehensive income (excluding adjustments to opening retained earnings) related to available-for-sale securities were negligible during fiscal 2019 and 2018. Reclassifications from accumulated other comprehensive income related to available-for-sale securities were $201 million during fiscal 2017 and were recorded in investment and other income, net. Reclassifications from accumulated other comprehensive income related to foreign currency translation adjustments and derivative instruments were negligible for all periods presented.
Share-based compensation expense. Total share-based compensation expense, related to all of our share-based awards, was comprised as follows (in millions):
 
2019
 
2018
 
2017
Cost of revenues
$
35

 
$
38

 
$
38

Research and development
725

 
594

 
588

Selling, general and administrative
277

 
251

 
288

Share-based compensation expense before income taxes
1,037

 
883

 
914

Related income tax benefit
(184
)
 
(140
)
 
(161
)
 
$
853

 
$
743

 
$
753

Other Income, Costs and Expenses. Other expenses in fiscal 2019 consisted of a $275 million charge for the fine imposed by the European Commission (EC) related to the Icera complaint (2019 EC fine) (Note 7) and $213 million in net restructuring and restructuring-related charges related to our Cost Plan (Note 10), partially offset by a $43 million gain due to the partial recovery of a fine we previously paid to the Korea Fair Trade Commission (KFTC) and a $31 million gain related to a favorable legal settlement.
Other expenses in fiscal 2018 consisted of a $2.0 billion charge related to a fee paid in connection with the termination of our purchase agreement to acquire NXP, a $1.2 billion charge for the fine imposed by the EC related to an investigation (2018 EC fine) (Note 7) and $629 million in restructuring and restructuring-related charges related to our Cost Plan, partially offset by a $676 million benefit related to the settlement of the Taiwan Fair Trade Commission (TFTC) investigation.
Other expenses for fiscal 2017 consisted of a $927 million charge related to the a fine imposed by the KFTC (Note 7), including related foreign currency losses, a $778 million charge related to the TFTC fine and $37 million in restructuring and restructuring-related charges related to our Strategic Realignment Plan that was completed in fiscal 2017.
Investment and Other Income, Net (in millions)
 
 
 
 
 
 
2019
 
2018
 
2017
Interest and dividend income
$
316

 
$
625

 
$
619

Net gains on marketable securities
288

 
41

 
456

Net gains on other investments
68

 
83

 
74

Impairment losses on marketable securities and other investments
(135
)
 
(75
)
 
(177
)
Net (losses) gains on derivative instruments
(14
)
 
(27
)
 
32

Equity in net losses of investees
(93
)
 
(145
)
 
(74
)
Net gains (losses) on foreign currency transactions
11

 
37

 
(30
)
 
$
441

 
$
539

 
$
900


Net gains on marketable securities included realized gains and losses of available-for-sale debt securities. During fiscal 2019 and 2018, gross realized gains or losses on sales of available-for-sale debt securities were negligible. During fiscal 2017, gross realized gains and losses on sales of available-for-sale debt securities were $361 million and $98 million, respectively.